- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT06001918
Nectero EAST System klinisk studie (stAAAble)
Randomisert kontrollert klinisk utprøving (RCT) av Nectero EAST-systemet for små til mellomstore abdominale aortaaneurismer (AAA) StaBiLisering: Evaluering av effektivitet.
The purpose of this randomized clinical trial is to treat patients with small to mid-sized abdominal aortic aneurysms (AAA), maximum diameter of 3.5 cm to 5.0 cm, using a locally delivered, single-dose endovascular treatment. The main question the study aims to answer is to demonstrate efficacy of the product for stabilization of these small to mid-sized AAA.The study will compare the treatment group to the typical standard of care for these patients, surveillance. All subjects will be followed at designated intervals at 30/60 days, 6, 12, 18 and 24 months with continued follow-up annually for up to 5 years.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Studietype
Registrering (Antatt)
Fase
- Fase 2
- Fase 3
Kontakter og plasseringer
Studiekontakt
- Navn: Charlene Knape
- Telefonnummer: 866-755-4744
- E-post: cknape@necteromedical.com
Studer Kontakt Backup
- Navn: Tracy Roberts
- Telefonnummer: (303)3964603
- E-post: troberts@necteromedical.com
Studiesteder
-
-
New South Wales
-
Randwick, New South Wales, Australia, 2031
- Rekruttering
- Prince of Wales Private Hospital- POW Vascular Institute
-
Hovedetterforsker:
- Ramon Varcoe
-
Ta kontakt med:
- Jade Goh
- Telefonnummer: 04 87 369 396
- E-post: pow.vascular.institute@gmail.com
-
-
-
-
Arizona
-
Scottsdale, Arizona, Forente stater, 85258
- Rekruttering
- Honor Health Scottsdale Shea Medical Center
-
Hovedetterforsker:
- Hasan Aldailami, MD
-
Ta kontakt med:
- HonorHealth Cardiovascular Research
- Telefonnummer: 480-323-1046
-
-
Colorado
-
Aurora, Colorado, Forente stater, 80045
- Aktiv, ikke rekrutterende
- University of Colorado
-
-
District of Columbia
-
Washington D.C., District of Columbia, Forente stater, 20010
- Rekruttering
- Medstar Washington Hospital Center
-
Hovedetterforsker:
- Steven Abramowitz, MD
-
Ta kontakt med:
- Kassaye Sesaba, MD
- Telefonnummer: 202-877-7452
- E-post: Kassaye.T.Sesaba@medstar.net
-
Ta kontakt med:
- Suman Singh, MD
- Telefonnummer: (202) 877-8475
- E-post: Suman.Singh@Medstar.net
-
-
Florida
-
Delray Beach, Florida, Forente stater, 33446
- Rekruttering
- Prime Vascular Institute
-
Hovedetterforsker:
- Joseph Ricotta, MD
-
Ta kontakt med:
- Jordan Sprechman
- Telefonnummer: 561-495-3145
- E-post: Jordan.Sprechman@tenethealth.com
-
Ta kontakt med:
- Alexia Medick
- E-post: Alexia.Medick@tenethealth.com
-
-
Georgia
-
Augusta, Georgia, Forente stater, 30912
- Rekruttering
- Medical College of Georgia
-
Hovedetterforsker:
- William Jordan, MD
-
Ta kontakt med:
- Natasha Flores
- E-post: nflores@augusta.edu
-
Ta kontakt med:
- Candelario Laserna
- Telefonnummer: 706-721-2199
- E-post: calaserna@augusta.edu
-
-
Illinois
-
Chicago, Illinois, Forente stater, 60637
- Rekruttering
- University of Chicago
-
Ta kontakt med:
- MacKenton Johnson
- Telefonnummer: 773-795-3639
- E-post: mackenton@bsd.uchicago.edu
-
Hovedetterforsker:
- Ross Milner, MD
-
Elk Grove, Illinois, Forente stater, 60007
- Har ikke rekruttert ennå
- Ascension Alexian Brothers
-
Hovedetterforsker:
- Jack Chamberlin, MD
-
-
Maine
-
Scarborough, Maine, Forente stater, 04074
- Rekruttering
- MaineMed Vascular Surgery
-
Hovedetterforsker:
- Kristina Giles, MD
-
Ta kontakt med:
- Kathryn Ackermann
- E-post: kathryn.ackermann@mainehealth.org
-
-
Massachusetts
-
Boston, Massachusetts, Forente stater, 02114
- Rekruttering
- Massachusetts General Hospital
-
Hovedetterforsker:
- Nikolaos Zacharias, MD
-
Ta kontakt med:
- Bonnie Chen
- E-post: BCHEN13@mgh.harvard.edu
-
Boston, Massachusetts, Forente stater, 02215
- Rekruttering
- Beth Israel Deaconess Medical Center
-
Hovedetterforsker:
- Marc Schermerhorn, MD
-
Ta kontakt med:
- Monica Goyal
- Telefonnummer: 617-632-7534
- E-post: mgoyal@bidmc.harvard.edu
-
Ta kontakt med:
- Fernando Moreno
- E-post: fmoreno@bidmc.harvard.edu
-
Worcester, Massachusetts, Forente stater, 01655
- Rekruttering
- University of Massachusetts
-
Ta kontakt med:
- Shauneen Valliere
- E-post: shauneen.valliere@umassmed.edu
-
Hovedetterforsker:
- Andres Schanzer, MD
-
-
Michigan
-
Royal Oak, Michigan, Forente stater, 48073
- Rekruttering
- Beaumont Health
-
Hovedetterforsker:
- Graham Long, MD
-
Ta kontakt med:
- Lisa Bliss
- E-post: lisa.bliss@corewellhealth.org
-
-
Missouri
-
St Louis, Missouri, Forente stater, 63110
- Rekruttering
- Washington University School of Medicine
-
Hovedetterforsker:
- Luis Sanchez, MD
-
Ta kontakt med:
- Briana K Langrehr, BSN
- E-post: briana.l@wustl.edu
-
-
Nebraska
-
Omaha, Nebraska, Forente stater, 68198
- Rekruttering
- University of Nebraska Medical Center
-
Hovedetterforsker:
- Jonathan Thompson, MD
-
Ta kontakt med:
- Jarod Phillips
- E-post: jarphillips@unmc.edu
-
-
New Hampshire
-
Lebanon, New Hampshire, Forente stater, 03766
- Rekruttering
- Dartmouth Hitchcock Medical Center
-
Hovedetterforsker:
- Rebecca Scully, MD
-
Ta kontakt med:
- Pauline Sirrell
- E-post: pauline.sirrell@hitchcock.org
-
-
New York
-
Rochester, New York, Forente stater, 14642
- Rekruttering
- University of Rochester
-
Ta kontakt med:
- Mary Bourret
- E-post: Mary_Bourret@URMC.Rochester.edu
-
Hovedetterforsker:
- Doran Mix, MD
-
Stony Brook, New York, Forente stater, 11794
- Har ikke rekruttert ennå
- Stony Brook Medicine
-
Hovedetterforsker:
- Rabih Chaer, MD
-
Ta kontakt med:
- Daria Shavarina
- E-post: Daria.Shavarina@stonybrookmedicine.edu
-
-
North Carolina
-
Durham, North Carolina, Forente stater, 27710
- Rekruttering
- Duke University Medical Center
-
Hovedetterforsker:
- Chandler Long, MD
-
Ta kontakt med:
- Ellen Burkett
- Telefonnummer: (919)681-1878
- E-post: ellen.jones@duke.edu
-
-
Ohio
-
Cincinnati, Ohio, Forente stater, 45219
- Rekruttering
- The Christ Hospital
-
Ta kontakt med:
- Jamie Elkins
- E-post: Jamie.Elkins@thechristhospital.com
-
Hovedetterforsker:
- Geoff Answini, MD
-
Cleveland, Ohio, Forente stater, 44106
- Rekruttering
- University Hospitals Cleveland
-
Hovedetterforsker:
- Jae Cho, MD
-
Ta kontakt med:
- Amy Kluge
- E-post: Amy.Kluge@UHhospitals.org
-
Cleveland, Ohio, Forente stater, 44195
- Rekruttering
- Cleveland Clinic
-
Hovedetterforsker:
- Francis Caputo, MD
-
Ta kontakt med:
- Laurie Ann Moennich
- E-post: MOENNIL@ccf.org
-
Columbus, Ohio, Forente stater, 43210
- Rekruttering
- The Ohio State University Wexner Medical Center
-
Ta kontakt med:
- Subh Das
- Telefonnummer: 614-366-6596
- E-post: subhashish.das@osumc.edu
-
Hovedetterforsker:
- Kristine Orion, MD
-
Columbus, Ohio, Forente stater, 43214
- Rekruttering
- Ohio Health Riverside
-
Hovedetterforsker:
- Joseph Campbell, MD
-
Ta kontakt med:
- Regan Moran
- E-post: Regan.Moran@ohiohealth.com
-
-
Oklahoma
-
Tulsa, Oklahoma, Forente stater, 74104
- Rekruttering
- Oklahoma Heart Institute
-
Hovedetterforsker:
- Julia Chen, MD
-
Ta kontakt med:
- Tia Whitaker
- E-post: Tia.Whitaker@hillcrest.com
-
-
Oregon
-
Portland, Oregon, Forente stater, 97239
- Rekruttering
- Portland VA Medical Center
-
Hovedetterforsker:
- Matthew Koopmann, MD
-
Ta kontakt med:
- Rachel Nelson
- E-post: Rachel.Nelson1@va.gov
-
-
Pennsylvania
-
Bethlehem, Pennsylvania, Forente stater, 18015
- Rekruttering
- St. Luke's University Health Network
-
Hovedetterforsker:
- Sharvil Sheth, MD
-
Ta kontakt med:
- Jena Hagerty
- Telefonnummer: 484-658-4982
- E-post: Jena.Hagerty@sluhn.org
-
Philadelphia, Pennsylvania, Forente stater, 19104
- Rekruttering
- Hospital of the University of Pennsylvania
-
Ta kontakt med:
- Carolina Reyes
- Telefonnummer: 215-615-8036
- E-post: carolina.reyes1@pennmedicine.upenn.edu
-
Hovedetterforsker:
- Grace Wang, MD
-
Philadelphia, Pennsylvania, Forente stater, 19107
- Rekruttering
- Jefferson Clinical Research Institute
-
Ta kontakt med:
- Jona Shperdheja
- E-post: Jona.Shperdheja@jefferson.edu
-
Hovedetterforsker:
- Michael Nooromid, MD
-
Pittsburgh, Pennsylvania, Forente stater, 15219
- Rekruttering
- University of Pittsburgh Medical Center
-
Ta kontakt med:
- Judith Brimmeier
- E-post: brimmeierja@upmc.edu
-
Hovedetterforsker:
- Raymond Eid, MD
-
-
South Carolina
-
Greenville, South Carolina, Forente stater, 29605
- Rekruttering
- Prisma Health
-
Hovedetterforsker:
- Mark P Androes, MD
-
Ta kontakt med:
- Nikita Kasinger
- E-post: Nikita.Kasinger@PrismaHealth.org
-
Ta kontakt med:
- Maggie Salle
- E-post: Margaret.Salle@PrismaHealth.org
-
-
South Dakota
-
Sioux Falls, South Dakota, Forente stater, 57108
- Rekruttering
- North Central Heart - A Division of Avera Heart Hospital
-
Hovedetterforsker:
- Michael Bacharach, MD
-
Ta kontakt med:
- Patty Eisenbraun, RN
- Telefonnummer: 605-977-5336
- E-post: peisenbraun@ncheart.com
-
-
Tennessee
-
Nashville, Tennessee, Forente stater, 37232
- Rekruttering
- Vanderbilt University Medical Center
-
Hovedetterforsker:
- John Curci, MD
-
Ta kontakt med:
- Celia Nunez
- E-post: celia.m.nunez@vumc.org
-
Ta kontakt med:
- Jennifer Scott
- E-post: jennifer.scott@vumc.org
-
Nashville, Tennessee, Forente stater, 37212
- Har ikke rekruttert ennå
- VA Tennessee Valley Healthcare System
-
Hovedetterforsker:
- John Curci, MD
-
Ta kontakt med:
- Sohpia Miner
- E-post: Sophia.Miner@va.gov
-
-
Texas
-
Houston, Texas, Forente stater, 77004
- Rekruttering
- Houston Healthcare
-
Hovedetterforsker:
- Kristofer Charlton-Ouw, MD
-
Ta kontakt med:
- Swathi Potla
- E-post: swathi.potla@hcahealthcare.com
-
Plano, Texas, Forente stater, 75093
- Rekruttering
- Baylor Scott & White Medical Center
-
Hovedetterforsker:
- William Shutze, MD
-
Ta kontakt med:
- Saba Arianpour
- E-post: Saba.Arianpour@BSWHealth.org
-
-
Utah
-
Salt Lake City, Utah, Forente stater, 84132
- Rekruttering
- University of Utah Hospital
-
Ta kontakt med:
- Julie Hales
- E-post: Julie.Hales@hsc.utah.edu
-
Hovedetterforsker:
- Cali Johnson, MD
-
-
Virginia
-
Fairfax, Virginia, Forente stater, 22031
- Rekruttering
- Inova Fairfax Medical Campus Inova Health Systems
-
Ta kontakt med:
- Bhruga Shah
- E-post: Bhruga.shah@inova.org
-
Hovedetterforsker:
- Kendal Endicott, MD
-
Norfolk, Virginia, Forente stater, 23507
- Rekruttering
- Sentara Health
-
Hovedetterforsker:
- David Dexter, MD
-
Ta kontakt med:
- Angela Zahn
- E-post: AXZAHN@sentara.com
-
-
Washington
-
Seattle, Washington, Forente stater, 98104
- Rekruttering
- University of Washington at Harborview Medical Center
-
Ta kontakt med:
- Allison Larimore
- E-post: alari@uw.edu
-
Hovedetterforsker:
- Benjamin Starnes, MD
-
-
Wisconsin
-
Green Bay, Wisconsin, Forente stater, 54301
- Rekruttering
- Bellin Memorial Hospital
-
Hovedetterforsker:
- Jason Ricci, MD
-
Ta kontakt med:
- Katie Guilliams
- E-post: Katherine.Guilliams@emplifyhealth.org
-
-
-
-
-
Auckland, New Zealand, 1023
- Rekruttering
- Auckland City Hospital
-
Ta kontakt med:
- Cynthia Corne
- Telefonnummer: 21505 +64 9 307 4949
- E-post: CorneC@adhb.govt.nz
-
Hovedetterforsker:
- Andrew Holden, A/Prof
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Males and females ≥21 to ≤85 years of age. Females must be of non-childbearing potential (menopause or sterilization).
- Subject understands the purpose of the trial, agrees to voluntarily participate in the trial, signs the informed consent and is willing to complete the follow-up according to the requirements of the protocol.
- Infrarenal atherosclerotic fusiform abdominal aortic aneurysm from 3.5 cm to 5.0 cm (male) and 3.5 cm to 4.5 cm (female).
- Infrarenal aortic neck ≥ 15 mm in length and ≤ 29 mm in diameter.
- Overall AAA treatment length (distal renal to distal inferior margin of the aneurysm) not to exceed 130 mm.
- Iliac and femoral artery access, vessel size and morphology allow endovascular access of 14F (or larger) introducer sheaths and catheters.
- Subject meets American Society of Anesthesiology (ASA) grade 1 through 3 criteria, inclusive.
- Subject has > three-year life expectancy.
- Subject is able and willing to comply with all required follow-up clinic visits including CT scans (pre-randomization, 6, 12, 18, 24 months and annually up to 5 years) and blood draws.
Exclusion Criteria:
- Subject has an acutely ruptured, leaking, dissecting or emergent aneurysm.
- Subject has a symptomatic infrarenal abdominal aortic aneurysm.
- Subject has a mycotic or infected aneurysm.
- Subject has current vascular injury due to trauma.
- Subject's aneurysm is thoracic, suprarenal or juxtarenal.
- Previous surgical or endovascular aneurysm repair for abdominal aortic aneurysm.
- Subject has anatomy of diffuse, ulcerated, or extensive (shaggy) thrombus in the neck of the AAA, that in the opinion of the vascular surgeon/investigator, could result in embolization of the thrombus.
- Subject has anatomy of calcification, and/or plaque within the ilio-femoral arteries or severe infrarenal neck angulation that may compromise or does not allow delivery of the Introducer Sheath or the delivery catheter of the Nectero EAST System.
- Subject has had a myocardial infarction within six (6) months prior to enrollment or elevated CK enzymes or troponin indicative of an evolving MI prior to procedure.
- Subject has current angina, unstable angina, or other active cardiac condition such as congestive heart failure III and IV, atrial arrhythmia, ventricular arrhythmia, or valvular disease, requiring intervention.
- Subject has undergone other major surgery within the 30 days prior to enrollment.
- Subjects with any transient ischemic attack (TIA) or ischemic stroke within 3 months.
- Known allergy to contrast material that cannot be adequately premedicated, delivery system materials (i.e., nylon, polyurethane) and/or pentagalloylglucose (PGG).
- Subject is morbidly obese or has other clinical conditions that severely inhibit X-ray visualization of the aorta.
- Subject has connective tissue/collagen disorder (e.g., Marfan syndrome, vascular Ehlers-Danlos Syndrome, Loeys-Dietz Syndrome, Eaton Syndrome, Bessel-Hagen disease, etc.).
- Known contraindication to undergoing angiography or receiving systemic anticoagulation during the procedure.
- Subject has active systemic infection.
- Subject is participating in another research trial that could interfere with the results of the trial (e.g., drug trial).
- Subject has other medical, social, or psychological problems that, in the opinion of the investigator, preclude them from participation in the trial and to undergo the procedures and evaluations pre- and post-treatment.
- Subject has dialysis dependent renal failure or baseline serum creatinine level >2.5mg/dL or eGFR < 45 mL/min/1.73m2.
- Subjects with aminotransferase (ALT and/or AST) which is ≥1.5x upper limit of normal (ULN) or TB that is our of normal range for the evaluating laboratory.
- Subjects that may not tolerate the lowering of their systolic blood pressure to approximately 100mmHg, should not be considered for this study or treated using the Nectero EAST System.
- Subjects that may not be able to tolerate transient occlusion of the aorta should not be considered for this study.
- Subjects with saccular AAA.
- Subjects with rapidly expanding AAA (previous diameter increases of ≥0.5 cm in 6-months or ≥1 cm in 1 year) as these should be evaluated for immediate repair.
- Subjects who are not suitable for the Nectero EAST System treatment, as determined by the investigator.
- Subjects with INR out of normal range for the evaluating laboratory for a subject not on anti-coagulant therapy; or INR >3 for a subject on anti-coagulant therapy.
- Subjects with active/acute or a history of unstable chronic liver disease or current liver disease including but not limited to liver transplant, known genetic disorders such as Gilbert syndrome or other liver diseases.
- Subjects with cirrhosis (e.g., known history or new clinical diagnosis by elastography with a fibrosis score of F3 or F4 and/or steatosis grade of S3).
- Subjects with uncontrolled alcohol use disorder or current alcohol use putting them at risk of liver disease: including consumption of above one standard drink per day for women and two standard drinks per day for men.
- Subjects with known right-sided heart failure or pathologically dilated inferior vena cava or hepatic veins indicative of congestive hepatopathy.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Treatment Arm
Participants assigned to the treatment arm will undergo an endovascular procedure using the Nectero EAST System to deliver the Stabilizer Infusion Solution directly inside the aneurysm. This is a one-time local delivery of the product. Following treatment, surveillance of their AAA will be conducted using CT scans at 6 months, 12 months, 18 months, 24 months, and annually for 5 years. Intervention: Drug: Stabilizer |
Treated subjects will undergo an endovascular procedure with the Nectero EAST system and receive the Stabilizer Infusion Solution (drug) within 30 days of the study eligibility by CT scan as a one-time local delivery of the drug. |
|
Ingen inngripen: Control Arm
Participants assigned to the control arm will undergo surveillance of their AAA using CT scans at 6 months, 12 months, 18 months, 24 months, and annually for 5 years. |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Primary Endpoint
Tidsramme: 24 months
|
The primary endpoint is the composite of all AAA-related death, rupture and repair (open-surgical, EVAR, or clinically indicated for repair as adjudicated by a committee of clinical experts blinded to the assigned arm). |
24 months
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Growth
Tidsramme: 24 months
|
The growth over time in aneurysm diameter based on CT core laboratory readings. |
24 months
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Daniel Clair, MD, Vanderbilt University Medical Center
- Hovedetterforsker: Grace Wang, MD, University of Pennsylvania
Publikasjoner og nyttige lenker
Hjelpsomme linker
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- EAST002
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .